Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 110Observational 4

Sponsor

Cancer Type

Thoracic 2Gynecologic 2

Conditions

Uterine Cervical Dysplasia 2Small Cell Lung Carcinoma 2

Interventions

Blood Specimen Collection 31Sorafenib 29Nivolumab 29Bevacizumab 26Data Collection 24Observation 23palbociclib 22Sunitinib 22radium Ra 223 dichloride 20enzalutamide 18Rituximab 18Ipilimumab 16regorafenib 15Drug Therapy 15Trastuzumab 14Docetaxel 14ribociclib 12exemestane 12atezolizumab 12Standard of Care 12darolutamide 11apalutamide 11Leuprolide 11Capecitabine 11Afatinib 11Bortezomib 10Anastrozole 10trastuzumab deruxtecan 9pembrolizumab 9avelumab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Topotecan × Clear all
NCT01345279 2017-05-30

Indirect Comparison Topotecan Cervical Carcinoma

GlaxoSmithKline

Completed
1 enrolled
Gynecologic

Uterine Cervical Dysplasia

NCT01037023 2015-04-15

Hycamtin PMS

GlaxoSmithKline

Completed
92 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00997061 2014-02-03

SCOT

GlaxoSmithKline

Completed
500 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT01160185 2010-07-12

Meta-analysis of Efficacy of Topotecan

GlaxoSmithKline

Completed
1 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡